Psoralen (Synonyms: Ficusin)

Name: Psoralen
Brand: MedChemExpress
SKU: HY-N0053
Rating: 5.0 (6 reviews)

Cat. No.: HY-N0053 Purity: 99.96%: Data Sheet
COA

SDS
Handling Instructions
FAQs
Technical Support

Psoralen (Ficusin) is a coumarin isolated from the seeds of Fructus Psoraleae. Psoralen exhibits a wide range of biological properties, including anti-cancer, antioxidant, antidepressant, anticancer, antibacterial, and antiviral, et al.

For research use only. We do not sell to patients.

CAS No. : 66-97-7

Size	Stock	Quantity

Free Sample (0.1 - 0.2 mg)	Apply Now
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO ready for reconstitution	In-stock	Estimated Time of Arrival: December 31
Solution
10 mM * 1 mL in DMSO	In-stock	Estimated Time of Arrival: December 31
Solid
5 mg	In-stock	Estimated Time of Arrival: December 31
10 mg	In-stock	Estimated Time of Arrival: December 31
25 mg	In-stock	Estimated Time of Arrival: December 31
50 mg	In-stock	Estimated Time of Arrival: December 31
100 mg	In-stock	Estimated Time of Arrival: December 31
200 mg	Get quote
500 mg	Get quote

or Bulk Inquiry

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 6 publication(s) in Google Scholar

Other Forms of Psoralen:

Psoralen (Standard) In-stock

6 Publications Citing Use of MCE Psoralen

Cell Imaging/Staining

Cell Proliferation/Viability Assay

Cell Migration/Invasion Assay

: Psoralen purchased from MedChemExpress. Usage Cited in: Biomedicines. 2024 Dec 31;13(1):73.; Nuclear staining of 4T1 with Pso (Psoralen) (10 nM; 1 h).

: Psoralen purchased from MedChemExpress. Usage Cited in: Biomedicines. 2024 Dec 31;13(1):73.; The combination of Pso (Psoralen) (10 nM; 1 h) and 3 J/cm² UVA had the greatest effect at B16-F10 with a 2.04-fold increase (p < 0.005).

: Psoralen purchased from MedChemExpress. Usage Cited in: In Vivo. 2025 Sep-Oct;39(5):2681-2702. [Abstract]; Cell viability of A549 cells treated with different concentrations of Psoralen (20-160 μg/mL) for 12, 24, and 48 h, measured using the CCK-8 assay.

: Psoralen purchased from MedChemExpress. Usage Cited in: In Vivo. 2025 Sep-Oct;39(5):2681-2702. [Abstract]; Effects of Psoralen (15-60 μg/mL) on A549 cell proliferation, assessed by the 5-ethynyl-2'-deoxyuridine (EdU) incorporation assay.

: Psoralen purchased from MedChemExpress. Usage Cited in: In Vivo. 2025 Sep-Oct;39(5):2681-2702. [Abstract]; Wound healing assay assessing the effect of different Psoralen (15-60 μg/mL) concentrations on A549 cell migration. Red lines indicate the wound edges, showing the extent of cell migration at different time points across treatment groups.

: Psoralen purchased from MedChemExpress. Usage Cited in: In Vivo. 2025 Sep-Oct;39(5):2681-2702. [Abstract]; Psoralen (15-60 μg/mL; 24 h) increases intracellular Fe²⁺ levels in A549 cells.

: Psoralen purchased from MedChemExpress. Usage Cited in: In Vivo. 2025 Sep-Oct;39(5):2681-2702. [Abstract]; Psoralen (15-60 μg/mL; 24 h) disrupts antioxidant defense and enhances lipid peroxidation in A549 cells. Western blot analysis of glutathione peroxidase 4 (GPX4) and solute carrier family 7 member 11 (SLC7A11) protein expression levels in A549 cells treated with psoralen psoralen , with quantitative analysis.

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

View All HIV Isoform Specific Products:

View All Isoforms

HIV HIV-1 HIV-2

Biological Activity
Purity & Documentation
References
Customer Review

Description

Cellular Effect

Cell Line	Type	Value	Description	References
A549	IC₅₀	>10 μM Compound: 20	Cytotoxicity against human A549 cells after 48 hrs by MTT assay Cytotoxicity against human A549 cells after 48 hrs by MTT assay	[PMID: 25710081]
B16	IC₅₀	>200 μg/mL Compound: 7	Inhibition of alpha-MSH-stimulated melanogenesis in mouse B16 cells assessed as melanin release after 72 hrs Inhibition of alpha-MSH-stimulated melanogenesis in mouse B16 cells assessed as melanin release after 72 hrs	[PMID: 22450129]
HCT-116	IC₅₀	45.6 μM Compound: 5	Cytotoxicity against human HCT116 cells after 96 hrs by MTT assay Cytotoxicity against human HCT116 cells after 96 hrs by MTT assay	[PMID: 23746477]
HEK293	IC₅₀	>167 μM Compound: 3	Cytotoxicity against HEK239 cells after 72 hrs by Alamar blue assay Cytotoxicity against HEK239 cells after 72 hrs by Alamar blue assay	[PMID: 20558060]
HL-60	IC₅₀	16 μM Compound: 1	Cytotoxicity against HL-60 (human fibrosarcoma) cell line; Range 0.4-16 uM Cytotoxicity against HL-60 (human fibrosarcoma) cell line; Range 0.4-16 uM	[PMID: 15837311]
HT-29	IC₅₀	41.7 μM Compound: 5	Cytotoxicity against human HT-29 cells after 96 hrs by MTT assay Cytotoxicity against human HT-29 cells after 96 hrs by MTT assay	[PMID: 23746477]
K562	IC₅₀	>10 μM Compound: 20	Cytotoxicity against human K562 cells after 48 hrs by MTT assay Cytotoxicity against human K562 cells after 48 hrs by MTT assay	[PMID: 25710081]
K562	IC₅₀	131 μM Compound: 5	Cytotoxicity against human K562 cells after 96 hrs by MTT assay Cytotoxicity against human K562 cells after 96 hrs by MTT assay	[PMID: 23746477]
LoVo	IC₅₀	16 μM Compound: 1	Cytotoxicity against LoVo (human intestinal adenocarcinoma) cell line; Range 0.4-16 uM Cytotoxicity against LoVo (human intestinal adenocarcinoma) cell line; Range 0.4-16 uM	[PMID: 15837311]

In Vitro

Psoralen (10-500 μM; 24-48 hours) inhibits cell viability in a concentration- and time-dependent manner in L02 and?HepG2 cells. In L02 cells, Psoralen at 400 μM does not significantly change extracellular LDH levels, and 400 μM or 450 μM psoralen inhibits 50–60% of cell viability^[1].
Psoralen (150-450 μM; 24 hours) induces significant S-phase arrest in L02 cells in time- and dose-dependent manners, but it does not exhibits significant change in the cycle distribution of HepG2 cells^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay^[1]

Cell Line:	L02 and HepG2 cells
Concentration:	10 μM, 50 μM,100 μM, 200 μM, 300 μM,400 μM,450 μM,500 μM
Incubation Time:	24 or 48 hours
Result:	Inhibited the viability of L02 and HepG2 cells mainly by suppressing cell proliferation rather than causing cell death.

Cell Cycle Analysis^[1]

Cell Line:	L02 and HepG2 cells
Concentration:	150 μM; 300 μM; 450 μM
Incubation Time:	24 or 48 hours
Result:	Induced cell S-phase arrest instead of causing cell apoptosis or death.

In Vivo

Psoralen (oral gavage; 17.5 mg/kg; 6 weeks) reduces the number of metastatic lesions and the rate of bone metastasis by 20% compared to vehicle-treated mice. It also reduces tumor infiltration and decreases the percentage of tumor cells in metastatic lesions by ~40% compared to vehicle in mice^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	Female nude (BALB/c nu/nu) mice^[2]
Dosage:	17.5 mg/kg
Administration:	Oral gavage; 17.5 mg/kg; 6 weeks
Result:	Inhibited metastasis of breast cancer to bone in vivo.

Clinical Trial

Molecular Weight

186.16

Formula

C₁₁H₆O₃

CAS No.

66-97-7

Appearance

Solid

Color

White to off-white

SMILES

O=C1C=CC2=CC3=C(OC=C3)C=C2O1

Structure Classification

Initial Source

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	2 years
	-20°C	1 year

Solvent & Solubility

In Vitro:

DMSO : 100 mg/mL (537.17 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

H₂O : < 0.1 mg/mL (insoluble)

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	5.3717 mL	26.8586 mL	53.7172 mL
5 mM	1.0743 mL	5.3717 mL	10.7434 mL
10 mM	0.5372 mL	2.6859 mL	5.3717 mL

View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

Molarity Calculator
Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

Concentration _(start)

Volume _(start)

Concentration _(final)

Volume _(final)

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (13.43 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Protocol 2

Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: 2.5 mg/mL (13.43 mM); Suspended solution; Need ultrasonic

This protocol yields a suspended solution of 2.5 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Protocol 3

Add each solvent one by one: 10% DMSO 90% Corn Oil
Solubility: ≥ 2.5 mg/mL (13.43 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL Corn oil, and mix evenly.

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Please enter your animal formula composition:

DMSO +

Tween-80 +

Saline

Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.

The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).

Calculation results:

Working solution concentration: mg/mL

Method for preparing stock solution: mg drug dissolved in μL DMSO (Stock solution concentration: mg/mL).

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).

Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.

If the continuous dosing period exceeds half a month, please choose this protocol carefully.

Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.

Purity & Documentation

Purity: 99.96%

Select Batch:

Data Sheet (280 KB) SDS (396 KB)

COA (250 KB) HNMR (219 KB) LCMS (92 KB)

Handling Instructions (2659 KB)

References

[1]. Li Yin, et al. A novel psoralen derivative-MPFC enhances melanogenesis via activation of p38 MAPK and PKA signaling pathways in B16 cells. Int J Mol Med. 2018 Jun;41(6):3727-3735. [Content Brief]

[2]. Wu C, et al. Psoralen inhibits bone metastasis of breast cancer in mice. Fitoterapia. 2013 Dec;91:205-10. [Content Brief]

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg

DMSO	1 mM	5.3717 mL	26.8586 mL	53.7172 mL	134.2931 mL
	5 mM	1.0743 mL	5.3717 mL	10.7434 mL	26.8586 mL
	10 mM	0.5372 mL	2.6859 mL	5.3717 mL	13.4293 mL
	15 mM	0.3581 mL	1.7906 mL	3.5811 mL	8.9529 mL
	20 mM	0.2686 mL	1.3429 mL	2.6859 mL	6.7147 mL
	25 mM	0.2149 mL	1.0743 mL	2.1487 mL	5.3717 mL
	30 mM	0.1791 mL	0.8953 mL	1.7906 mL	4.4764 mL
	40 mM	0.1343 mL	0.6715 mL	1.3429 mL	3.3573 mL
	50 mM	0.1074 mL	0.5372 mL	1.0743 mL	2.6859 mL
	60 mM	0.0895 mL	0.4476 mL	0.8953 mL	2.2382 mL
	80 mM	0.0671 mL	0.3357 mL	0.6715 mL	1.6787 mL
	100 mM	0.0537 mL	0.2686 mL	0.5372 mL	1.3429 mL

Psoralen Related Classifications

Help & FAQs

Do most proteins show cross-species activity?
Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Psoralen66-97-7FicusinApoptosisHIVInfluenza VirusHuman immunodeficiency virusInhibitorinhibitorinhibit

Your Recently Viewed Products:

Product Name

Requested Quantity *

Applicant Name *

Salutation

Email Address *

Phone Number *

Department

Organization Name *

City

State

Country or Region *

Remarks

Product Name

Lot #

Applicant Name *

Email Address *

Phone Number

Department *

Organization Name *

Country or Region *

Remarks

Name
Email *

	Sorry, but the email address you supplied was invalid.

Psoralen (Synonyms: Ficusin)

Customer Review

Other Forms of Psoralen:

Psoralen Related Antibodies

6 Publications Citing Use of MCE Psoralen

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

View All HIV Isoform Specific Products:

Biological Activity

Purity & Documentation

References

Customer Review

Psoralen Related Antibodies

Molarity Calculator

Dilution Calculator

Complete Stock Solution Preparation Table

Psoralen Related Classifications

Keywords:

Your Recently Viewed Products:

Customer Review

Request for HNMR Report

SAFETY DATA SHEET (SDS)

Request for HNMR Report